Hospitals and Payers Initial market focus is acute care pain management after total joint replacement using the Sotiras wearable smart drug delivery device with feedback control. With costs reportedly covered by insurance providers, there is a clear path to hospital procurement, orthopedic departments, and PACU workflows. Consider pilots that demonstrate opioid-sparing benefits and improved pain control to drive adoption.

Payer Reimbursement Payer-centric reimbursement potential: leverage insurer coverage to drive adoption and work toward broader coverage for the device and related services. Build economic value cases centered on reduced opioid prescriptions, lower risk of dependency, and potential savings from shorter hospital stays and fewer complications. Engage payers, PBMs, and GPOs to support formulary inclusion and patient access.

Data Driven Care Data driven care enablement: the solution runs on a cloud stack (Google Cloud) and modern frontend technologies, enabling remote monitoring, dosing history, and clinician dashboards. This can deliver compelling value for hospitals pursuing outcome data and value-based care. Align with IT and EHR teams on interoperability, security, and privacy to accelerate deployment.

Strategic Partnerships Strategic partnerships and distribution: Runatek is a small team with patents pending, which can benefit from collaborations with established medical device distributors, orthopedic suppliers, or large health systems to accelerate market access. Explore licensing or co development deals with bigger medtech players to scale manufacturing and reach. Emphasize the device's opioid-sparing advantage and potential IP moat to attract partners.

Expansion Opportunities Expansion opportunities and market timing: after anchoring post surgical pain management, there is potential to broaden to other surgeries or outpatient pain indications. Build clinical evidence and navigate regulatory steps to support expansion, while pursuing payer acceptance and international market opportunities. Consider staged geographic rollout in health systems with high elective surgery volumes.